Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down
admin 15th March 2018 Uncategorised 0The biopharma industry faced plenty of uncertainty in 2017, but for most companies, the year delivered a rebound from stagnation, EP Vantage reports. Some rebounded far more than others—and some went the other direction.
More: Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down
Source: fierce